Natixis Advisors LLC Purchases 101,167 Shares of GE HealthCare Technologies Inc. $GEHC

Natixis Advisors LLC raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 21.6% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 568,481 shares of the company’s stock after purchasing an additional 101,167 shares during the period. Natixis Advisors LLC’s holdings in GE HealthCare Technologies were worth $42,693,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also made changes to their positions in GEHC. True North Advisors LLC increased its stake in shares of GE HealthCare Technologies by 2.0% during the third quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock valued at $525,000 after buying an additional 139 shares during the period. Klingman & Associates LLC grew its holdings in GE HealthCare Technologies by 4.0% during the 3rd quarter. Klingman & Associates LLC now owns 3,634 shares of the company’s stock worth $273,000 after acquiring an additional 139 shares in the last quarter. Colonial Trust Advisors increased its position in GE HealthCare Technologies by 11.1% during the 3rd quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock valued at $104,000 after purchasing an additional 139 shares during the period. Exchange Traded Concepts LLC raised its holdings in shares of GE HealthCare Technologies by 1.3% in the 3rd quarter. Exchange Traded Concepts LLC now owns 11,490 shares of the company’s stock valued at $863,000 after purchasing an additional 150 shares in the last quarter. Finally, Modera Wealth Management LLC lifted its position in shares of GE HealthCare Technologies by 3.5% in the 2nd quarter. Modera Wealth Management LLC now owns 4,500 shares of the company’s stock worth $333,000 after purchasing an additional 152 shares during the period. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

NASDAQ:GEHC opened at $75.63 on Tuesday. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. The firm has a market cap of $34.47 billion, a price-to-earnings ratio of 16.59, a price-to-earnings-growth ratio of 1.63 and a beta of 1.03. The company has a 50 day moving average price of $81.66 and a 200-day moving average price of $78.62. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion during the quarter, compared to analysts’ expectations of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The business’s revenue was up 7.1% compared to the same quarter last year. During the same period in the previous year, the business posted $1.45 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be given a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is 3.07%.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on GEHC shares. Evercore boosted their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a research note on Thursday, February 5th. Jefferies Financial Group boosted their price target on GE HealthCare Technologies from $95.00 to $105.00 and gave the stock a “buy” rating in a research report on Thursday, December 11th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Stifel Nicolaus boosted their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a “buy” rating in a report on Wednesday, February 4th. Finally, Wells Fargo & Company increased their price target on shares of GE HealthCare Technologies from $95.00 to $97.00 and gave the company an “overweight” rating in a research report on Thursday, February 5th. Seven equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $92.50.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.